跳至主要内容
临床试验/NL-OMON38413
NL-OMON38413已完成不适用

The Neo Non-Randomized Hypertension Study, a Study of Baroreflex Hypertension Therapie in Refractory Hypertension - Neo Non-Randomized Hypertension Study

CVRx Inc0 个研究点目标入组 9 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
CVRx Inc
入组人数
9

研究概览

简要总结

Trial is onging in other countries

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Age at least 21 years and no more than 80 years.
  • Office cuff systolic blood pressure (SBP) >= 140 mmHg
  • Normal anatomy of carotic artery bifurcations
  • An optimal stable anti-hypertensive therapy
  • not pregnant and contemplating pregnancy during study period
  • compliant on therapy

排除标准

  • known of suspected baroreflex failure or autonomic neuropathy
  • Body Mass Index above 45
  • Myocardial Infarction, unstable angina, syncope or CVA within the past 3 months
  • Carotic atherosclerosis producing a 50% or greater reduction in diameter
  • Prior surgery, radiation, or endovascular stent placement in the carotid sinus
  • Hypertension secondary to an identifiable and treatable cause other than
  • sleep apnoea.

研究者

发起方
CVRx Inc

相似试验